I gydnabod y cynnydd sydd wedi digwydd, symud y cyllid ar gyfer y driniaeth gan ddefnyddio’r cyffuriau Ranibizumab ac Aflibercept o Lywodraeth Cymru i’r byrddau iechyd. Isod, rwy’n nodi’n fanylach hanes a chefndir y driniaeth ar gyfer dirywiad macwlaidd gwlyb sy’n gysylltiedig â henaint.Cefndir
In recognition of the progress made, we are now moving the funding from the management of the Welsh Government to the health boards for the treatment of wet AMD using the drug Ranibizumab and Aflibercept.  I set out below, in more detail, the history and background to the treatment of wet AMD.Background